Error: Could not add to watchlist. X
+ Watchlist

Summit Therapeutics PLC

SUMM:LN
London
190.000
GBp
0.000
0.00%
As of 10/16/2017
Open
190.000
Day Range
190.000 - 190.000
Volume
0
Previous Close
190.000
52Wk Range
141.500 - 265.000
1 Yr Return
8.57%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
190.000
Day Range
190.000 - 190.000
Volume
0
Previous Close
190.000
52Wk Range
141.500 - 265.000
1 Yr Return
8.57%
YTD Return
32.40%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.061
Market Cap (m GBp)
134.196
Shares Outstanding (m)
70.629
Price/Sales (TTM)
5.12
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.90%
% Price Change
+0.63%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
Address
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
Phone
44-123-544-3939
Show More